Cairo: Bahrain has become the second country in the world after the UK granting an emergency use authorisation for the Pfizer/BioNTech vaccine against COVID-19.
Bahrain’s National Health Regulatory Authority (NHRA) confirmed approving the vaccine that followed a study conducted by the regulator and the Health Ministry’s Inoculation Committee based on data from Pfizer on effectiveness and safety of its vaccine, the Bahraini news agency BNA reported.
The vaccine will be available for high-risk groups including old people and sufferers of chronic diseases, the agency added.
Last month, Bahrain approved the emergency use of the Sinopharm vaccine against COVID-19 for frontline workers.
NHRA Chief Executive Officer Dr Mariam Al Jalahma said the regulator had held meetings with the producing company’s team in the US and its representatives to get answers to all queries.،
Bahrain so far has registered a tally of 87,600 virus cases and 341 related deaths.